A Phase I, Open-Label Study Evaluating The Pharmacokinetics of Components of S-1 Patients With Impaired Hepatic Function.
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Taiho Pharmaceutical
- 11 Aug 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Feb 2008 The expected completion date for this trial is now 1 Jul 2008 as reported by ClinicalTrials.gov.